PART I We are a global commercial-stage medical technology company focused on creating diagnostic and screening products to identify abnormalities of the GI tract. We develop advanced imaging and AI technologies in creating such products while maximizing the flexibility, convenience, profitability, and safety of patient care. We are a Delaware company, incorporated in 2005. Our corporate headquarters is located in Saratoga, California. Currently, our GI-tract capsule endoscopy solution comprises...
Q2 FY2026 — expected 2026-09-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001378325-26-000010 | EDGAR | 96K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001378325-25-000040 | EDGAR | 59K words |
| 2025-08-14 | 2025-06-30 | 0001378325-25-000010 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001378325-26-000008 | EDGAR | 3K words |
| 2026-03-20 | 0001378325-26-000004 | EDGAR | — |
| 2026-03-13 | 0001378325-26-000002 | EDGAR | — |
| 2025-12-29 | 0001378325-25-000043 | EDGAR | — |
| 2025-11-13 | 0001378325-25-000039 | EDGAR | — |
| 2025-11-10 | 0001378325-25-000031 | EDGAR | — |
| 2025-11-03 | 0001378325-25-000027 | EDGAR | — |
| 2025-09-26 | 0001378325-25-000022 | EDGAR | — |
| 2025-09-03 | 0001378325-25-000018 | EDGAR | — |
| 2025-08-14 | 0001378325-25-000008 | EDGAR | — |
19 total filings indexed. 6 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001378325 |
| Ticker | CV |
| Exchange | Nasdaq |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | DE |
| Website | https://www.capsovision.com |
| Listed | 2025-07-02 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report